Current PNH treatments may not be enough
The most common treatments available today are called C5 inhibitors and are given by infusion.
C5 inhibitors only address intravascular hemolysis (IVH), not extravascular hemolysis (EVH). This can lead to ongoing hemolysis and lower-than-normal hemoglobin levels.